510(k) device
Myriad SPECTRA Light Source
Nico Corporation · Diagnostic Neurosurgical Microscope Filter (QFX, Class II) · First FDA decision Mar 14, 2024, newest Mar 14, 2024Brain tumors
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Myriad SPECTRA Light"
MAUDE reports
0
Brand "Myriad SPECTRA Light", since 2015
PubMed studies
0
Mentioning "Myriad SPECTRA Light"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Myriad SPECTRA Light Source
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K232567 · Decided Mar 14, 2024 · 203 days after receipt
Device type: Diagnostic Neurosurgical Microscope Filter (QFX) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Myriad SPECTRA Light", any status and sponsor, newest update first.
No registered device study names "Myriad SPECTRA Light".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Myriad SPECTRA Light", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFX
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- NICO Myriad Illumination Pack Product No. NN-1000 11g Illumination Sleeve/Fiber; Product No. NN-1001 13g Illumination Sleeve/FiberOpen, Classified
Z-0600-2026 · Started Oct 31, 2025 · Posted by FDA Nov 26, 2025
Reason given: Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.
Cause as FDA categorized it: Under Investigation by firm · Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI)
Published research
The most relevant PubMed records for "Myriad SPECTRA Light"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFX.
- Blue 400Carl Zeiss Meditec, AG · 510(k) 2024
- cCeLL405VPIX Medical, Inc. · 510(k) 2026
- Affirm 400Digital Surgery Systems, Inc. (D.B.A True Digital Surgery) · 510(k) 2026
- Leica FL400Leica Microsystems (Schweiz) AG · De Novo 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.